Blackstone invests $125m in NantPharma
The investment will help the company become premier provider of bio-derived products and critically needed injectables, according to Blackstone. NantWorks and NantPharma chairman Patrick Soon-Shiong said NantPharm will
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.